Agnete Witness Præst Jensen
PhD fellow
Olsen Group
Blegdamsvej 3B
2200 København N
ORCID: 0000-0001-8868-7481
1 - 3 out of 3Page size: 10
- 2023
- Published
Phase 2 study of ipilimumab, nivolumab, and tocilizumab combined with stereotactic body radiotherapy in patients with refractory pancreatic cancer (TRIPLE-R)
Chen, I. M., Donia, M., Chamberlain, C. A., Jensen, Agnete Witness Præst, Draghi, A., Theile, S., Madsen, K., Hasselby, Jane Preuss, Toxværd, A., Høgdall, Estrid Vilma Solyom, Lorentzen, T., Wilken, E. E., Geertsen, P., Svane, Inge Marie, Johansen, Julia Sidenius & Nielsen, D., 2023, In: European Journal of Cancer. 180, p. 125-133 9 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Proteomics to study cancer immunity and improve treatment
Franciosa, Giulia, Kverneland, Anders Handrup, Jensen, Agnete Witness Præst, dqp123, dqp123 & Olsen, Jesper Velgaard, 2023, In: Seminars in Immunopathology. 45, 11 p., 241–251.Research output: Contribution to journal › Review › Research › peer-review
- Published
TCR-engaging scaffolds selectively expand antigen-specific T-cells with a favorable phenotype for adoptive cell therapy
Tvingsholm, S. A., Frej, M. S., Rafa, V. M., Hansen, U. K., Ormhøj, M., Tyron, A., Jensen, A. W. P., Kadivar, M., Bentzen, A. K., Munk, K. K., Aasbjerg, G. N., Ternander, J. S. H., Heeke, C., Tamhane, T., Schmess, C., Funt, S. A., Kjeldsen, J. W., Kverneland, A. H., Met, Ö., Draghi, A. & 4 others, , 2023, In: Journal for ImmunoTherapy of Cancer. 11, 8, 16 p., e006847.Research output: Contribution to journal › Journal article › Research › peer-review
ID: 189377138
Most downloads
-
83
downloads
Exercise Oncology and Immuno-Oncology; A (Future) Dynamic Duo
Research output: Contribution to journal › Review › Research › peer-review
Published -
16
downloads
Proteomics to study cancer immunity and improve treatment
Research output: Contribution to journal › Review › Research › peer-review
Published